Study of serum amyloid A level among different clinical phenotypes of Egyptian patients with Common Variable Immunodeficiency
Ain Shams Medical Journal · 08.11.2026 · 0-0
DOI: 10.21608/asmj.2026.511490.1688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ain Shams Medical Journal, online erschienen am 08.11.2026. Verfasst von Sara Said Ragab und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Common variable immunodeficiency (CVID) is one of the inborn errors of immunity with five clinical phenotypes mainly infection. Serum amyloid A (SAA) may lead to amyloidosis in prolonged inflammation. Chronic inflammatory status in CVID put patients at risk of developing secondary amyloidosis.Evaluation of SAA levels among CVID phenotypes and impact of intravenous immunoglobulin (IVIG) therapy on SAA levels.A case control prospective study included 40 participants, 20 CVID patients and 20 healthy controls. Medical history, examination, Complete blood count (CBC), renal and hepatic function, CRP, thyroid profile, CD4, CD8, CD19, CD4/CD8 ratio, SAA and Immunoglobulin levels before and after 15 days of a single dose of IVIG therapy were done for all patients.Mean age of CVID patients was 32.00 ± 8.49 years old ;75% of cases being males; lower weight and height compared to controls (p = 0.003 for both), diagnosis age was at 24.45 ± 11.16 years; mean diagnosis delay was 7.55 ± 6.98 years. Infections-only, enteropathy(30%)and autoimmunity (25%) were frequent phenotypes. SAA levels showed a significant decrease post-IVIG (p0.05).Baseline SAA levels showed significant negative correlations with platelet count (r = -0.592, p = 0.006), CRP (r = -0.506, p = 0.023), and ALT (r = -0.550, p = 0.012).Serum amyloid A levels significantly decreased following IVIG therapy with a negative correlation with CRP, ALT and platelets which may indicate its usefulness as a biomarker of inflammatory status in CVID patients but independently from clinical phenotypes.
Zitieren
APA
Ragab, S. S., AboAli, F. H., Rady, M. A. A., Tawfik, M. M., & Mohamed, M. F. (2026). Study of serum amyloid A level among different clinical phenotypes of Egyptian patients with Common Variable Immunodeficiency. Ain Shams Medical Journal, 0(0), 0-0. https://doi.org/10.21608/asmj.2026.511490.1688
Vancouver
Ragab SS, AboAli FH, Rady MAA, Tawfik MM, Mohamed MF. Study of serum amyloid A level among different clinical phenotypes of Egyptian patients with Common Variable Immunodeficiency. Ain Shams Medical Journal. 2026;0(0):0-0. doi:10.21608/asmj.2026.511490.1688
BibTeX
@article{Ragab2026,
author = {Ragab, Sara Said and AboAli, Fawzia Hassan and Rady, Maha Ahmed Abdel and Tawfik, Monica Malak and Mohamed, Manar F},
title = {Study of serum amyloid A level among different clinical phenotypes of Egyptian patients with Common Variable Immunodeficiency},
journal = {Ain Shams Medical Journal},
year = {2026},
volume = {0},
number = {0},
pages = {0--0},
doi = {10.21608/asmj.2026.511490.1688}
}
EUVIMED